Md Hamza, Sheikh Nazmul Islam, Nowroj Ahmed, Md Shafiqul Islam
Severe asthma remains a challenging condition despite advancements in conventional therapies. Biologics have revolutionized treatment by targeting specific inflammatory pathways, offering personalized therapy for patients with uncontrolled disease. This review explores the current landscape of biologic therapies, including their mechanisms of action, dosing regimens, efficacy, and safety profiles. We also discuss emerging biologic targets and future directions in asthma management. Chest Heart J. 2024; 48(2) : 108-114